BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10277744)

  • 21. What the new Medicare rules mean to pathologists.
    Cole GW
    MLO Med Lab Obs; 1983 May; 15(5):50-4. PubMed ID: 10299168
    [No Abstract]   [Full Text] [Related]  

  • 22. Hospitals for radical new cost rules.
    MLO Med Lab Obs; 1983 Jan; 15(1):27-8. PubMed ID: 10298828
    [No Abstract]   [Full Text] [Related]  

  • 23. The retainer fee contract.
    Schoen I
    Pathologist; 1981 Aug; 35(8):438-9. PubMed ID: 10252492
    [No Abstract]   [Full Text] [Related]  

  • 24. Generating revenue through laboratory testing.
    Hannon F
    Hosp Entrep Newsl; 1987 Jun; 3(1):1-2, 8. PubMed ID: 10325197
    [No Abstract]   [Full Text] [Related]  

  • 25. Calling it like it is: reimbursement narcosis.
    Schoen I
    Pathologist; 1984 Nov; 38(11):747-8. PubMed ID: 10273593
    [No Abstract]   [Full Text] [Related]  

  • 26. Is that new instrument a winner?
    Stafford AC
    MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
    [No Abstract]   [Full Text] [Related]  

  • 27. Hospitals can pull in extra 5% profit by marketing their slack lab capacity.
    Nathanson M
    Mod Healthc; 1983 May; 13(5):64, 67. PubMed ID: 10260321
    [No Abstract]   [Full Text] [Related]  

  • 28. TEFRA: a primer for the uninitiated.
    Kenety WH
    Pathologist; 1983 Sep; 37(9):655-8. PubMed ID: 10299327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow lab computer market picks up.
    LaViolette S
    Mod Healthc; 1979 Nov; 9(11):46, 48. PubMed ID: 492117
    [No Abstract]   [Full Text] [Related]  

  • 30. Fulfilling Medicare's criteria for consultative services.
    Pastuszak WT
    Pathologist; 1985 Jun; 39(6):31-4. PubMed ID: 10300151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COBRA coils for strike against clinical lab fees.
    MLO Med Lab Obs; 1986 Jun; 18(6):25-6. PubMed ID: 10300963
    [No Abstract]   [Full Text] [Related]  

  • 32. Practicing pathology in New Jersey.
    Harrer WV
    Pathologist; 1983 Aug; 37(8):557-9. PubMed ID: 10310297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instituting change to cut lab costs.
    Pelton TN
    Pathologist; 1985 Jul; 39(7):17-20. PubMed ID: 10272022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments of the American College of Pathologists on proposed regulations on payment for physician services in institutional practice.
    Pathologist; 1982 Dec; 36(12):suppl ii-xii. PubMed ID: 10261169
    [No Abstract]   [Full Text] [Related]  

  • 35. Teaming up with administrators to set prospective payment policy.
    Shaw LD
    Pathologist; 1984 Jun; 38(6):352-3. PubMed ID: 10273529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition for the health dollar: the pathologist's share.
    Olsen HV
    Pathologist; 1983 Feb; 37(2):122-4. PubMed ID: 10261175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-house software monitors and projects costs.
    Sealfon MS
    MLO Med Lab Obs; 1987 Jan; 19(1):75-6. PubMed ID: 10280455
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquisition alternatives for capital equipment.
    Burrows SB
    Pathologist; 1983 May; 37(5):326-8. PubMed ID: 10261179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathologist and the hospital clinical laboratory.
    Gruhn JG
    Pathologist; 1982 Oct; 36(10):532-6. PubMed ID: 10261168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A compensation incentive plan for pathologists in academic practice.
    Cummings KC
    Pathologist; 1986 Oct; 40(10):21-6. PubMed ID: 10279095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.